Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies.
Ito T, Ishigami M, Yamamoto T, Mizuno K, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H, Yasuda S, Toyoda H, Yokota K, Hase T, Nishio N, Maeda O, Kato M, Hashimoto N, Hibi H, Kodera Y, Sone M, Ando Y, Akiyama M, Shimoyama Y, Fujishiro M.
Ito T, et al. Among authors: shimoyama y.
Hepatol Int. 2021 Oct;15(5):1278-1287. doi: 10.1007/s12072-021-10238-y. Epub 2021 Aug 9.
Hepatol Int. 2021.
PMID: 34373964